Kaitlin Peters, MD
Dermatology · Pittsburgh, PANPI 1750624839
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 868 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,812 and has fallen 58.8% since, to $1,571 in 2025.
Across 868 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- UCB, Inc.$1K
- Pfizer$1K
- Novartis$951
- Sanofi$933
- plus $8K from 31 others
What the payments were for
- Food & beverage$15,19494%
- Education$9636%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 161 | $2,468 |
| AbbVie(2 entities) | 100 | $1,947 |
| UCB, Inc. | 88 | $1,206 |
| Pfizer | 59 | $1,041 |
| Novartis | 59 | $951 |
| Sanofi | 50 | $933 |
| Lilly USA, LLC | 51 | $909 |
| Incyte Corporation | 36 | $805 |
| Galderma Laboratories, L.p. | 39 | $802 |
| LEO Pharma Inc. | 35 | $800 |
| Amgen | 29 | $764 |
| Sun Pharmaceutical Industries Inc. | 32 | $658 |
| Journey Medical Corporation | 17 | $508 |
| Regeneron Healthcare Solutions, Inc. | 15 | $396 |
| E.r. Squibb & Sons, L.L.C. | 24 | $372 |
| Arcutis Biotherapeutics, Inc. | 10 | $287 |
| Biofrontera Inc. | 14 | $271 |
| Dermavant Sciences, Inc. | 8 | $122 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $121 |
| Genentech USA, Inc. | 4 | $87 |
| Regeneron | 2 | $84 |
| Prugen, Inc. Pharmaceuticals | 3 | $83 |
| VYNE Pharmaceuticals Inc. | 4 | $77 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $72 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Bristol Myers Squibb | 4 | $67 |
| Almirall LLC | 4 | $59 |
| Mayne Pharma Commercial LLC | 2 | $33 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Blueprint Medicines Corporation | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Organon | 1 | $17 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $17 |
| Aclaris Therapeutics, Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $16 |
| EPI Health, LLC | 1 | $13 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,157 in reported general payments places this provider in the 85th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 21 | $150,392 |
| Dupixent PenDupilumab | 23 | $86,767 |
| Clobetasol Propionate | 112 | $4,111 |
| Fluorouracil | 61 | $4,009 |
| Pimecrolimus | 18 | $3,415 |
| Tacrolimus | 41 | $3,306 |
| Ketoconazole | 165 | $2,670 |
| Calcipotriene | 30 | $2,638 |
| Dutasteride | 63 | $2,078 |
| Metronidazole | 38 | $2,073 |
| Clindamycin Phosphate | 37 | $1,527 |
| Ciclopirox | 53 | $1,178 |
| Doxycycline Hyclate | 72 | $1,164 |
| Mycophenolate Mofetil | 12 | $959 |
| Fluocinonide | 28 | $895 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Pittsburgh
- Neil NirenPittsburgh$574K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
- Joe TungPittsburgh$404K
- Charles MountPittsburgh$189K
- Timothy PattonPittsburgh$72K
- Daniel KaplanPittsburgh$46K
- Hassane ZarourPittsburgh$44K
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.